New cholesterol fighter enters first human tests
Disease control
Not yet recruiting
This is a very early study to check the safety of a new experimental drug called RN5681, which is designed to lower 'bad' cholesterol (LDL-C) and another fat particle called Lp(a). It will test single doses in 60 healthy volunteers to see how their bodies react to and process the…
Phase: PHASE1 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC